Rosuvastatin

(Crestor®)

Crestor®

Drug updated on 10/23/2023

Dosage FormTablet (oral: 5 mg, 10 mg, 20 mg, 40 mg
Drug ClassHMG Co-A reductase inhibitor (statin)
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated to reduce the risk of stroke, myocardial infarction, and arterial revascularization procedures in adults without established coronary heart disease who are at increased risk of cardiovascular (CV) disease based on age, hsCRP ≥2 mg/L, and at least one additional CV risk factor.
  • Indicated as an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia.
  • Indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) and slow the progression of atherosclerosis in adults.
  • Indicated as an adjunct to diet to reduce LDL-C in adults and pediatric patients aged 8 years and older with heterozygous familial hypercholesterolemia (HeFH).
  • Indicated as an adjunct to other LDL-C-lowering therapies, or alone if such treatments are unavailable, to reduce LDL-C in adults and pediatric patients aged 7 years and older with homozygous familial hypercholesterolemia (HoFH).
  • Indicated as an adjunct to diet for the treatment of adults with; primary dysbetalipoproteinemia; hypertriglyceridemia.